Corpus ID: 78632827

Commercialisation of Advanced Therapies : - A Study of the EU Regulation on Advanced Therapy Medical Products

@inproceedings{Mansnrus2016CommercialisationOA,
  title={Commercialisation of Advanced Therapies : - A Study of the EU Regulation on Advanced Therapy Medical Products},
  author={Juli Mansn{\'e}rus},
  year={2016}
}
Advanced therapy medicinal products (ATMPs), is a heterogeneous class of modern biotechnology medicines encompassing products based on genes (gene therapy medical products, GTMPs), cells (somatic cell therapy medical products, CTMPs) and tissues (tissue engineering medical products, TEPs). ATMPs provide new therapeutic opportunities for many diseases and debilitating injuries to the human body, particularly in such disease areas where conventional treatments have proved insufficient. Since… Expand
1 Citations
Funding breakthrough therapies: A systematic review and recommendation.

References

SHOWING 1-10 OF 272 REFERENCES
Clinical development of advanced therapy medicinal products in Europe: evidence that regulators must be proactive.
European Regulatory Tools for Advanced Therapy Medicinal Products
CAT – The new committee for advanced therapies at the European Medicines Agency
  • P. Celis
  • Medicine
  • Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz
  • 2009
The advanced therapy classification procedure
...
1
2
3
4
5
...